New KIM-1 ELISA Kit from Enzo Life Sciences, Inc. is Most Sensitive for Quantifying Biomarker of Early Stage Kidney Injury and Disease. Strengthening its position as an innovator in tools for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results